CHICAGO and FORT WORTH, Texas, July 17, 2025 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company focused on ...
September is Childhood Cancer Awareness month. According to the National Cancer Institute, childhood cancer is the leading cause of disease-related death past infancy in children and adolescents. The ...
Brigatinib monotherapy in children with R/R ALK+ ALCL, IMT, or other solid tumors: Results from the BrigaPED (ITCC-098) phase 1 study. This is an ASCO Meeting Abstract from the 2024 ASCO Annual ...
Ewing sarcoma is a rare, aggressive cancer that primarily strikes children and adolescents, yet it can present in infants, where it is exceptionally uncommon. U.S. registry data show an incidence of ...
Sarcomas, a diverse group of malignancies, exhibit substantial heterogeneity in both biological behavior and microenvironment, influencing their response to immunotherapy. Although pembrolizumab is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results